S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Dr. Olga Arbitman Integrates Naprapathy and Tech at Health Box Clinic

In a Glenview clinic, Dr. Olga Arbitman is shifting the focus of physical rehabilitation by merging manual naprapathy with advanced technologies like shockwave and PEMF therapy. Her approach prioritizes the body's kinetic function, treating movement restrictions rather than just individual symptoms to restore long-term mobility for her patients.

Dr. Olga Arbitman Integrates Naprapathy and Tech at Health Box Clinic
Photo: Bio & News

Dr. Arbitman, a licensed Doctor of Naprapathy, developed her practice through a foundation in exercise physiology before graduating from the National College of Naprapathic Medicine in 2011. This background influences her clinical philosophy: she views technology as a supportive tool rather than a standalone solution. Every session begins with an assessment of how the body compensates for pain, ensuring that interventions are tailored to specific movement patterns.

Naprapathy targets connective tissues—specifically fascia, ligaments, and tendons—to improve structural integrity. Because Illinois remains one of the few states where the discipline is formally licensed, many patients encounter the practice for the first time when seeking alternatives to standard pharmaceutical or surgical routes. Operating out of 3633 W Lake Ave, Arbitman’s work at Health Box Clinic is currently highlighted on MyTSV, a video directory showcasing regional specialists in the Chicago area.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!